Worldwide Cancer Market: Trend Analysis

Worldwide Cancer Market: Trend Analysis published by Koncept Analytics in June, 2008. This report consists of 25 pages and the price starts from US $ 800.

Introduction

The global cancer market represents the most far-reaching pharmaceutical market in the world. Asia-Pacific has the highest prevalence in liver cancer. China is the largest market, with 350,000 patients diagnosed with the disease in 2006. Breast cancer is the most common cancer for women and accounts for nearly one in three cancer cases diagnosed in women.

The most common types are prostate cancer, female breast cancer, and lung cancer and account for more than half of all cancer cases treated with radiation therapy. Stomach cancer was the fourth most common type of cancer in the world in 2007, with an estimated one million new cases. More than two-thirds of new cases have occurred in developing countries.

The report throws light on the different types of cancers, new cases and deaths. It also analyzes the global radiation therapy and oncology market. It starts with a discussion of the worldwide diagnosis and therapy equipment market and then analyzes cancer drugs market. The report also discusses the major players with a discussion of their key business strategies.

1. Cancer Market Overview

• 1.1 Worldwide Market
  • 1.1.1 Worldwide Cancer Cases and Deaths
  • 1.1.2 Major Cancer Causes in Developed/Developing Countries

2. Types of Cancer and Affected Population

• 2.1 Lung Cancer
• 2.2 Prostate Cancer
• 2.3 Breast Cancer
• 2.4 Stomach Cancer

3. Demographic Distribution of Cancer

• 3.1 By Gender
  • 3.1.1 Cancer Growth in Developed/Developing Countries
• 3.2 Childhood Cancer

4. Global Diagnosis and Therapy Equipment Market

• 4.1 Oncology Market Size
• 4.2 Targeted Cancer Therapies
• 4.3 Radiation Therapy Equipment Market
  • 4.3.1 Worldwide Market Value
  • 4.3.2 Worldwide Market Share
• 4.4 Anticancer Drugs Market
  • 4.4.1 Vectibix Global Market

5. Market Outlook

• 5.1 Projected Oncology Sales Breakdown

6. Company Profiles

• 6.1 GlaxoSmithKline
  • 6.1.1 Overview
  • 6.1.2 New Product Development
• 6.2 Roche
  • 6.2.1 Overview
  • 6.2.2 Major Anticancer Drugs
• 6.3 Bristol Myers
  • 6.3.1 Overview
  • 6.3.2 Business Strategies
  • 6.3.3 Strategic Alliances and Arrangements
  • 6.3.4 Innovation of New Drug for Breast Cancer Patients

• Worldwide Prevalence and Deaths from Specific Cancers (2006-07)
• Most Common Types of New Cancer Cases by Region (2007)
• Cancer Growth in Developed Countries by Cancer Type (2007)
• Cancer Growth in Developing Countries by Cancer Type (2007)
• Global Radiation Equipment Market Value (2004-07)
• Worldwide Radiation Therapy - Share of Leading Players (2004-07)
• Annual Cost per Patient for Leading Anti-cancer Drugs
• GlaxoSmithKline - Divisional Sales (2007)
• Roche - Top Anticancer Drugs by Sales (2007)

• Worldwide New Cancer Cases by Type (2006)
• Worldwide Cancer Deaths by Type (2006)
• Major Cancer Causes in Developed Countries (2006)
• Major Cancer Causes in Developing Countries (2006)
• Incidence of Cancer by Region (2020E)
• Lung Cancer in US - Annual Incidence & Deaths (2000-06)
• Prostate Cancer in US - Annual Incidence & Deaths (2000-06)
• Breast Cancer in US - Annual Incidence & Deaths (2000-06)
• Cancer Cases (by type) in Children <15 Years in Europe (2006)
• Cancer Cases (by type) in Children <15 Years in Africa (2006)
• Cancer Cases (by type) in Children <15 Years in Latin America (2006)
• Cancer Cases (by type) in Children <15 Years in East Asia (2006)
• Market Share of Global Oncology Market (2006)
• Cancer Therapy by Modality (2006)
• Cancer Therapy by Target (2006)
• Worldwide Vectibix Market (2006-10E)
• Global Oncology Sales Breakdown by Incidences (2015E)
• Roche - Sales by Therapeutic Area (2007)

Related Reports